ADIM
DOCS icon

Alpha DNA Investment Management’s Doximity DOCS Stock Holding History

Alpha DNA Investment Management’s Portfolio DOCS Stock Details DOCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-9,410
Closed -$502K – 60
2024
Q4 		$502K Buy
+9,410
New +$461K 0.19% 102

Other funds holding DOCS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Alpha DNA Investment Management's DOCS Position: Q1 2025 in Review

Alpha DNA Investment Management sold out of Doximity (DOCS) in Q1 2025, closing a stake of 9,410 shares — an estimated $502K sold.

Alpha DNA Investment Management first reported a position in DOCS in Q4 2024 and held it in 1 quarter. The position peaked at $502K in Q4 2024. 491 funds tracked by Wall St. Rank hold DOCS as of Q1 2025.

  • Alpha DNA Investment Management reported no remaining Doximity position as of Q1 2025 after selling out during the quarter.
  • Alpha DNA Investment Management sold 9,410 Doximity shares in Q1 2025, an estimated $502K.
  • Alpha DNA Investment Management first reported a position in Doximity in Q4 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Doximity position peaked at $502K in Q4 2024.
  • 491 funds tracked by Wall St. Rank held Doximity as of Q1 2025.

Based on Alpha DNA Investment Management's 13F filing for Q1 2025, filed 19 May 2025.